Clinical Trial

Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant

Study acronym: FIRE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Non-infectious posterior uveitis is a chronic inflammatory eye disease that can lead to irreversible retinal damage and visual impairment due to repeated inflammatory relapses. The fluocinolone acetonide intravitreal implant is approved for the prevention of inflammatory relapses in this condition, but data from real-world clinical practice remain limited, particularly regarding the intensity of relapses over time. This multicenter retrospective observational study aims to evaluate the frequency and intensity of inflammatory recurrences in adult patients with non-infectious posterior uveitis treated with a fluocinolone acetonide implant. Clinical and imaging data routinely collected during follow-up will be analyzed over a three-year period to better characterize long-term outcomes, treatment burden, and safety in real-life conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-13.
Trial Details
NCT Number NCT07423442
Lead Sponsor Nantes University Hospital
Conditions Noninfectious Posterior Uveitis, Uveitis, Posterior, Uveitic Macular Edema
Enrollment 100 participants
Start Date 2026-06
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-24